Cutaneous Basal Cell Carcinoma In Situ: A Review of the World Literature.
Cohen PR, Kurzrock R.
Cureus. 2024 Sep 19;16(9):e69691. doi: 10.7759/cureus.69691. eCollection 2024 Sep.
Single-cell sequencing highlights heterogeneity and malignant progression in actinic keratosis and cutaneous squamous cell carcinoma.
Zou DD, Sun YZ, Li XJ, Wu WJ, Xu D, He YT, Qi J, Tu Y, Tang Y, Tu YH, Wang XL, Li X, Lu FY, Huang L, Long H, He L, Li X.
Elife. 2023 Dec 15;12:e85270. doi: 10.7554/eLife.85270.
Cutaneous Basal Cell Carcinoma In Situ: A Case Series.
Cohen PR.
Cureus. 2022 Sep 23;14(9):e29479. doi: 10.7759/cureus.29479. eCollection 2022 Sep.
Superficial Basal Cell Carcinoma of the Skin Is a Cutaneous Basal Cell Carcinoma In Situ.
Cohen PR.
Skinmed. 2024 Aug 2;22(3):165-167. eCollection 2024.
Functionally distinct cancer-associated fibroblast subpopulations establish a tumor promoting environment in squamous cell carcinoma.
Schütz S, Solé-Boldo L, Lucena-Porcel C, Hoffmann J, Brobeil A, Lonsdorf AS, Rodríguez-Paredes M, Lyko F.
Nat Commun. 2023 Sep 5;14(1):5413. doi: 10.1038/s41467-023-41141-9.
Clinical ABCDE rule for early melanoma detection.
Duarte AF, Sousa-Pinto B, Azevedo LF, Barros AM, Puig S, Malvehy J, Haneke E, Correia O.
Eur J Dermatol. 2021 Dec 1;31(6):771-778. doi: 10.1684/ejd.2021.4171.
Merkel cell carcinoma in situ: A systematic review of prognosis and management.
Truong K, Goldinger SM, Chou S, Howle JR, Veness MJ, Fernandez-Peñas P, Varey AHR.
Australas J Dermatol. 2022 Feb;63(1):e6-e12. doi: 10.1111/ajd.13758. Epub 2021 Dec 7.
S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma"- update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care.
Heppt MV, Leiter U, Steeb T, Alter M, Amaral T, Bauer A, Bechara FG, Becker JC, Breitbart EW, Breuninger H, Diepgen T, Dirschka T, Eigentler T, El Gammal AKS, Felcht M, Flaig MJ, Follmann M, Fritz K, Grabbe S, Greinert R, Gutzmer R, Hauschild A, Hillen U, Ihrler S, John SM, Kofler L, Koelbl O, Krause-Bergmann A, Kraywinkel K, Krohn S, Langer T, Loquai C, Löser CR, Mohr P, Nashan D, Nothacker M, Pfannenberg C, Salavastru C, Schmitz L, Stockfleth E, Szeimies RM, Ulrich C, Voelter-Mahlknecht S, Vordermark D, Weichenthal M, Welzel J, Wermker K, Wiegand S, Garbe C, Berking C.
J Dtsch Dermatol Ges. 2023 Oct;21(10):1249-1262. doi: 10.1111/ddg.15231.
Safety and Efficacy of TGF-beta1/COX-2 Silencing Therapeutic in Adults With Cutaneous Squamous Cell Carcinoma In Situ.
Nestor M, Berman B, Lu P, Molyneaux M.
J Drugs Dermatol. 2022 May 1;21(5):472-477. doi: 10.36849/JDD.6384.
Cutaneous Squamous Cell Carcinoma In Situ on a Fingernail Treated With HPV Vaccine.
Selm LC, Morr C, Badiavas EV, Nichols A, Ioannides T.
J Drugs Dermatol. 2024 Apr 1;23(4):275-276. doi: 10.36849/JDD.7507.
